Literature DB >> 10849726

Review: the role of membrane peptidases in immune functions.

U Lendeckel1, T Kähne, D Riemann, K Neubert, M Arndt, D Reinhold.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10849726     DOI: 10.1007/0-306-46826-3_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.

Authors:  Carmen Wolke; Alexander Teumer; Karlhans Endlich; Nicole Endlich; Rainer Rettig; Sylvia Stracke; Beate Fiene; Simone Aymanns; Stephan B Felix; Anke Hannemann; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-30

2.  Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range.

Authors:  Sonia M Tusell; Stephanie A Schittone; Kathryn V Holmes
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

3.  TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.

Authors:  Stephanie Bertram; Ronald Dijkman; Matthias Habjan; Adeline Heurich; Stefanie Gierer; Ilona Glowacka; Kathrin Welsch; Michael Winkler; Heike Schneider; Heike Hofmann-Winkler; Volker Thiel; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

4.  The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.

Authors:  Christoph Röcken; Konrad Neumann; Stacy Carl-McGrath; Hermann Lage; Matthias P A Ebert; Jutta Dierkes; Christoph A Jacobi; Sinan Kalmuk; Peter Neuhaus; Ulf Neumann
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

5.  Feline and canine coronaviruses: common genetic and pathobiological features.

Authors:  Sophie Le Poder
Journal:  Adv Virol       Date:  2011-07-31

6.  Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.

Authors:  Xuejian Wang; Fanbo Jing; Huawei Zhu; Hao Fang; Jian Zhang; Wenfang Xu
Journal:  Fundam Clin Pharmacol       Date:  2011-04       Impact factor: 2.748

Review 7.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

8.  Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.

Authors:  Sandrine Bouchet; Ruoping Tang; Fanny Fava; Ollivier Legrand; Brigitte Bauvois
Journal:  Oncotarget       Date:  2014-09-30

9.  Contribution of the porcine aminopeptidase N (CD13) receptor density to porcine epidemic diarrhea virus infection.

Authors:  Eeuri Nam; Changhee Lee
Journal:  Vet Microbiol       Date:  2009-12-28       Impact factor: 3.293

10.  A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry.

Authors:  Fandan Meng; Siqingaowa Suo; Dante S Zarlenga; Yingying Cong; Xiaowei Ma; Qiong Zhao; Xiaofeng Ren
Journal:  Virology       Date:  2014-03-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.